Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Are The Market Size Estimates For The Digital Diagnostics Market?

In the last few years, the size of the digital diagnostics market has seen exponential growth. It is projected to expand from a value of $1.76 billion in 2024 to an estimated $2.15 billion in 2025, representing a compound annual growth rate (CAGR) of 22.4%. Several factors have contributed to this growth during the historical period, including increased investment and funding, heightened awareness and training, a boost in research and development funding, a heightened focus on ESG factors, and greater incorporation of patient-centric approaches.

In the coming years, significant growth is projected for the digital diagnostics market, expanding to a value of $4.8 billion by 2029 with a compound annual growth rate (CAGR) of 22.2%. The growth projected in this forecast period is attributed to international health campaigns, healthcare globalization, cultural momentum towards digital solutions, healthcare institution support, and increased diagnostic capabilities. Notable trends during this forecast period consist of expansion in point-of-care testing, the burgeoning growth of telemedicine solutions, the development of cutting-edge software solutions, widening of digital pathology solutions, and the use of blockchain technology for securing data.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20748&type=smp

What Drivers Are Accelerating Expansion Of The Digital Diagnostics Market?

The projection for growth in the digital diagnostics market is set to surge, given the upturn in chronic illness cases. The escalating count of such illnesses can attribute to factors such as increasing age, obesity rates, sedentary lifestyles, environmental factors as well as greater recognition and diagnosis of these medical conditions. Digital diagnostics plays a crucial role in chronic illness management, allowing persistent monitoring, early detection of complications, and tailoring treatment plans that improve patient outcomes and disease management in the long run. Notably, the World Health Organization, an intergovernmental organization based in Switzerland, reported around 20 million fresh cancer cases and nearly 9.7 million cancer-associated deaths in 2022. Lung cancer topped the chart with around 2.5 million new cases, representing 12.4% of all new cases, followed by breast cancer for women with about 2.3 million incidences (11.6%), colorectal cancer with almost 1.9 million cases (9.6%), prostate cancer with roughly 1.5 million cases (7.3%), and stomach cancer with approximately 970,000 cases (4.9%). In view of the sheer burden, high Human Development Index (HDI) countries are predicted to witness the highest surge in incidences, with an additional 4.8 million fresh cases forecasted for 2050 compared to 2022 figures. Consequently, the soaring number of chronic illness cases kindles the expansion of the digital diagnostics market.

What Are The Key Segment Trends Observed In The Digital Diagnostics Market?

The digital diagnosticsmarket covered in this report is segmented –

1) By Product: Hardware; Software; Services

2) By Application: Cardiology; Gynecology; Infectious Diseases; Oncology; Diabetes; Other Applications

3) By End-Users: Hospitals And Clinics; Clinical Laboratories; Pharmaceutical And Biotechnology Companies; Academic And Research Institutes; Other End-Users

Subsegments:

1 By Hardware: Diagnostic Devices; Wearable Devices; Sensors And Monitoring Equipment

2) By Software: Diagnostic Software; Data Analytics Software; Artificial Intelligence (AI) And Machine Learning Software; Cloud-Based Platforms

3) By Services: Diagnostic Testing Services; Telemedicine And Remote Monitoring Services; Data Management And Analytics Services

Which Disruptive Trends Are Driving Change Across The Digital Diagnostics Market?

Leading corporations in the digital diagnostics market are prioritizing the creation of progressive technology products, like digital cytology systems. The aim is to improve diagnostic precision, optimize workflows, and facilitate remote evaluations using sophisticated imaging and Artificial Intelligence (AI) driven instruments. A digital cytology system is a cutting-edge diagnostic platform that puts imaging technology and AI to use for the analysis and interpretation of cytological specimens, leading to effective and accurate medical diagnoses. For example, in February 2024, Hologic Inc., a medical technology company in the U.S., secured approval from the U.S. Food and Drug Administration (FDA) for its Genius Digital Diagnostics System that includes the Genius Cervical AI algorithm. The Genius Digital Diagnostics System has the distinction of being the first and only FDA-approved digital cytology platform, which combines AI based on deep learning with comprehensive volumetric imaging to detect pre-cancerous lesions and cells of cervical cancer. This system, unlike conventional methods, where a Pap test collected cervical cells are manually inspected under a microscope, digitalizes the glass slides and uses AI for highlighting key cells noticed by cytologists and pathologists.

Who Are The Major Stakeholders Operating In The Digital Diagnostics Market?

Major companies operating in the digital diagnostics market are Hoffmann-La Roche Holding AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers , Koninklijke Philips N.V., General Electric Company, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Hologic Inc., bioMérieux S.A., Bio-Rad Laboratories Inc., Fulgent Genetics Inc., Guardant Health Inc., Tempus Labs Inc., Genomic Health Inc., EDX Medical Inc., PathAI Inc., Healthy.io Ltd., BrightInsight Inc., Digital Diagnostics Inc., Brainomix Limited, DnaNudge Ltd., GRAIL Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/digital-diagnostics-global-market-report

What Regional Factors Are Accelerating Growth In The Digital Diagnostics Market?

North America was the largest region in the digital diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=20748&type=smp

Browse Through More Reports Similar to the Global Digital Diagnostics Market 2025, By The Business Research Company

Dental Adhesives And Sealants Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dental-adhesives-and-sealants-global-market-report

Dental Bonding Agent Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dental-bonding-agent-global-market-report

Dental Bone Graft Substitutes Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dental-bone-graft-substitutes-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model